Six years before the start of the COVID-19 pandemic, an Ebola outbreak in West Africa had people fearing the possibility of a ...
New research this month shows that the experimental antiviral obeldesivir prevented up to 100% of deaths in monkeys infected ...
The pill protected 80 per cent of the cynomolgus macaques and 100 per cent of the rhesus macaques, which are biologically ...
The acting assistant administrator for global health at USAID, who was put on administrative leave, said Ebola response activities were not approved and no funds were made available.
A day after getting exposed to the Ebola virus, ten monkeys then received an Obeldesivir pill daily for ten days, while three control monkeys received no treatment and died. The study found that ...
Recurrent outbreaks of the Ebola virus disease (EVD) pose substantial threats to Africa's health systems. Despite advancements such as vaccines and therapeutics, successful outbreak containment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback